Table 2. Patient characteristics.
Variables | ZJG | TX | χ2 | P |
---|---|---|---|---|
N (%) | N (%) | |||
Sex | ||||
Male | 191(69.71) | 234(74.05) | 1.37 | 0.241 |
Female | 83(30.29) | 82(25.95) | ||
Age (year) | ||||
<60 | 211(77.01) | 166(52.53) | 38.11 | <0.001 |
≥60 | 63(22.99) | 150(47.47) | ||
Residence | ||||
Local patient | 149(54.38) | 310(98.10) | 162.41 | <0.001 |
Migrant patient | 125(45.62) | 6(1.90) | ||
Education | ||||
Illiterate | 24(8.76) | 65(20.57) | 42.79 | <0.001 |
Primary school | 70(25.55) | 90(28.48) | ||
Junior middle school | 106(38.69) | 129(40.82) | ||
Senior high school | 44(16.06) | 27(8.54) | ||
University or above | 30(10.95) | 5(1.58) | ||
Treatment history* | ||||
Yes | 21(7.95) | 42(14.29) | 5.57 | 0.018 |
No | 243(92.05) | 252(85.71) | ||
Hospitalization | ||||
Yes | 100(36.50) | 49(15.51) | 34.25 | <0.001 |
No | 174(63.50) | 267(84.49) | ||
Adverse drug reactions | ||||
Yes | 74(27.99) | 123(38.92) | 9.37 | 0.002 |
No | 200(72.99) | 193(61.08) | ||
Intake of liver protective drugs | ||||
Yes | 168(61.31) | 61(19.30) | 109.06 | <0.001 |
No | 106(38.69) | 255(80.70) |
*: some missing data.